CLINICAL RESEARCH: HEART FAILURE
Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure
Maria Rosa Costanzo, MD, FACC*,*,
Maya E. Guglin, MD, FACC ,
Mitchell T. Saltzberg, MD, FACC*,
Mariell L. Jessup, MD, FACC ,
Bradley A. Bart, MD, FACC ,
John R. Teerlink, MD, FACC||,
Brian E. Jaski, MD, FACC¶,
James C. Fang, MD, FACC#,
Erika D. Feller, MD, FACC**,
Garrie J. Haas, MD, FACC,
Allen S. Anderson, MD, FACC,
Michael P. Schollmeyer, DVM,
Paul A. Sobotka, MD, FACC for the UNLOAD Trial Investigators
* Midwest Heart Foundation, Lombard, Illinois
John D. Dingell VA Medical Center, Division of Cardiology, Department of Medicine, Wayne State University, Detroit, Michigan
Division of Cardiology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Division of Cardiology, Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota
|| San Francisco Veterans Affairs Medical Center/University of California, San Francisco, California
¶ San Diego Cardiac Center, Sharp Memorial Hospital, San Diego, California
# Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Harvard University, Boston, Massachusetts
** Division of Cardiology, Department of Medicine, University of Maryland, Baltimore, Maryland
Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio
Division of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois
CHF Solutions, Brooklyn Park, Minnesota
Manuscript received April 10, 2006;
accepted July 6, 2006.
* Reprint requests and correspondence: Dr. Maria Rosa Costanzo, Midwest Heart Foundation, Edward Heart Hospital, 4th Floor, 801 South Washington Street, P.O. Box 3226, Naperville, Illinois 60566. (Email: mcostanzo{at}midwestheart.com).
Partially presented as a Late Breaking Clinical Trial at the 55th Scientific Sessions of the American College of Cardiology, March 11–14, 2006, Atlanta, Georgia.
OBJECTIVES: This study was designed to compare the safety and efficacy of veno-venous ultrafiltration and standard intravenous diuretic therapy for hypervolemic heart failure (HF) patients.
BACKGROUND: Early ultrafiltration may be an alternative to intravenous diuretics in patients with decompensated HF and volume overload.
METHODS: Patients hospitalized for HF with  2 signs of hypervolemia were randomized to ultrafiltration or intravenous diuretics. Primary end points were weight loss and dyspnea assessment at 48 h after randomization. Secondary end points included net fluid loss at 48 h, functional capacity, HF rehospitalizations, and unscheduled visits in 90 days. Safety end points included changes in renal function, electrolytes, and blood pressure.
RESULTS: Two hundred patients (63 ± 15 years, 69% men, 71% ejection fraction  40%) were randomized to ultrafiltration or intravenous diuretics. At 48 h, weight (5.0 ± 3.1 kg vs. 3.1 ± 3.5 kg; p = 0.001) and net fluid loss (4.6 vs. 3.3 l; p = 0.001) were greater in the ultrafiltration group. Dyspnea scores were similar. At 90 days, the ultrafiltration group had fewer patients rehospitalized for HF (16 of 89 [18%] vs. 28 of 87 [32%]; p = 0.037), HF rehospitalizations (0.22 ± 0.54 vs. 0.46 ± 0.76; p = 0.022), rehospitalization days (1.4 ± 4.2 vs. 3.8 ± 8.5; p = 0.022) per patient, and unscheduled visits (14 of 65 [21%] vs. 29 of 66 [44%]; p = 0.009). No serum creatinine differences occurred between groups. Nine deaths occurred in the ultrafiltration group and 11 in the diuretics group.
CONCLUSIONS: In decompensated HF, ultrafiltration safely produces greater weight and fluid loss than intravenous diuretics, reduces 90-day resource utilization for HF, and is an effective alternative therapy. (The UNLOAD trial; http://clinicaltrials.gov/ct/show/NCT00124137?order=1; NCT00124137
[ClinicalTrials.gov]
).
|
Abbreviations and Acronyms
| | HF = heart failure |
|
Related Article
-
The Challenge of Correcting Volume Overload in Hospitalized Patients With Decompensated Heart Failure
- Uri Elkayam, Parta Hatamizadeh, and Munir Janmohamed
J. Am. Coll. Cardiol. 2007 49: 684-686.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur. Heart J.,
October 1, 2008;
29(19):
2388 - 2442.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Greenberg, B. Czerska, R. M. Delgado, R. Bourge, M. R. Zile, M. Silver, M. Klapholz, E. Haeusslein, M. R. Mehra, P. Mather, et al.
Effects of Continuous Aortic Flow Augmentation in Patients With Exacerbation of Heart Failure Inadequately Responsive to Medical Therapy: Results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM)
Circulation,
September 16, 2008;
118(12):
1241 - 1249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Wingate and D. L.-M. Wiegand
End-of-Life Care in the Critical Care Unit for Patients With Heart Failure
Crit. Care Nurse,
April 1, 2008;
28(2):
84 - 94.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Teerlink
Learning the points of COMPASS-HF: assessing implantable hemodynamic monitoring in heart failure patients.
J. Am. Coll. Cardiol.,
March 18, 2008;
51(11):
1080 - 1082.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Ronco, J. A. Kellum, R. Bellomo, and A. A. House
Potential Interventions in Sepsis-Related Acute Kidney Injury
Clin. J. Am. Soc. Nephrol.,
March 1, 2008;
3(2):
531 - 544.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kazory and E. A. Ross
Contemporary Trends in the Pharmacological and Extracorporeal Management of Heart Failure: A Nephrologic Perspective
Circulation,
February 19, 2008;
117(7):
975 - 983.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the year in JACC 2007.
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
490 - 512.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.H. W. Tang and G. S. Francis
The Year in Heart Failure
J. Am. Coll. Cardiol.,
December 11, 2007;
50(24):
2344 - 2351.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kazory, A. A. Ejaz, and E. A. Ross
The UNLOAD Trial: A "Nephrologic" Standpoint
J. Am. Coll. Cardiol.,
August 21, 2007;
50(8):
820 - 820.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Costanzo and on behalf of the UNLOAD Trial Investigators
Reply
J. Am. Coll. Cardiol.,
August 21, 2007;
50(8):
820 - 821.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Gheorghiade, M. A. Konstam, J. C. Burnett Jr, L. Grinfeld, A. P. Maggioni, K. Swedberg, J. E. Udelson, F. Zannad, T. Cook, J. Ouyang, et al.
Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure: The EVEREST Clinical Status Trials
JAMA,
March 28, 2007;
297(12):
1332 - 1343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. W. Yancy
Climbing the Mountain of Acute Decompensated Heart Failure: The EVEREST Trials
JAMA,
March 28, 2007;
297(12):
1374 - 1376.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Allen and C. M. O'Connor
Management of acute decompensated heart failure
Can. Med. Assoc. J.,
March 13, 2007;
176(6):
797 - 805.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Ultrafiltration for Acute Volume Overload in HF?
Journal Watch Cardiology,
February 28, 2007;
2007(228):
4 - 4.
[Full Text]
|
|
|
|
|
|
|
U. Elkayam, P. Hatamizadeh, and M. Janmohamed
The Challenge of Correcting Volume Overload in Hospitalized Patients With Decompensated Heart Failure
J. Am. Coll. Cardiol.,
February 13, 2007;
49(6):
684 - 686.
[Full Text]
[PDF]
|
|
|
|
